Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species

Chen C, Liu Yu, Liu R, Ikenoue T, Guan KL, Liu Yang, Zheng P · 2008 · Journal of Experimental Medicine · Atlas ID CHE2008

What this study shows

Showed why blood stem cells must keep mTOR LOW. Deleting TSC1 (which unleashes mTOR) drove resting stem cells into rapid division, flooded them with reactive oxygen species, and burned out their ability to self-renew. An antioxidant rescued them. A key link between mTOR, stem-cell exhaustion, and tissue aging.

Abstract

ShowHide

The tuberous sclerosis complex (TSC)-mammalian target of rapamycin (mTOR) pathway is a key regulator of cellular metabolism. We used conditional deletion of Tsc1 to address how quiescence is associated with the function of hematopoietic stem cells (HSCs). We demonstrate that Tsc1 deletion in the HSCs drives them from quiescence into rapid cycling, with increased mitochondrial biogenesis and elevated levels of reactive oxygen species (ROS).

Read the full abstract on PubMed →

At a glance

Evidence type A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse (conditional Tsc1 knockout)); the code names the system studied -- animal work can be rigorous and still not be human data.
Study type4 - Animal Study
Model systemMouse (conditional Tsc1 knockout)
JournalJournal of Experimental Medicine
Year2008
Peer reviewedYes
Record last updated2026-08-22
SourceDOI 10.1084/jem.20081297 · PMID 18809716 · Free full text (PMC2556783)

Extracted findings

InterventionGenetic (Tsc1 conditional knockout)
TargetTSC-mTOR / mitochondrial biogenesis / ROS
ModelMouse (conditional Tsc1 KO)
EffectTSC-mTOR maintains hematopoietic stem cell quiescence and function by repressing mitochondrial biogenesis and ROS
DoseMice (6 wk old) treated with polyinosine-polycytidine (pIpC) every other day for 2 wk to induce Tsc1 deletion.
Sample sizeVariable, e.g., n=3 to n=10 mice per group depending on the experiment.
Effect sizeTsc1 deletion reduced quiescent LT-HSCs from ~70% to <15% and increased BrdU incorporation nearly fourfold (from 13% to ~60%); resulted in an ~50% reduction in white blood cell counts (P = 0.001).
LimitationsIt is unlikely that the HSCs in the spleen are fully functional because HSCs have reduced self-renewal when their niche in BM is disrupted.

In the Atlas

Related topics

TSC1/TSC2mTORC1

More studies on this topic

Cite this paper

ShowHide 
Chen, C., Liu Yu, Liu, R., Ikenoue, T., Guan, K. L., Liu Yang, & Zheng, P. (2008). TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20081297

@article{CHE2008,
  author       = {Chen, C. and Liu Yu and Liu, R. and Ikenoue, T. and Guan, K. L. and Liu Yang and Zheng, P.},
  title        = {{TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species}},
  journal      = {Journal of Experimental Medicine},
  year         = {2008},
  doi          = {10.1084/jem.20081297},
  note         = {PMID: 18809716},
}

Cite this Atlas record

The record is the Atlas's own work — the evidence label, the extracted findings and the links. It is cited as part of the dataset, not as the paper. 

Barton, O. (2026). Oliver's mTOR Atlas (record CHE2008) [Data set]. https://mtor-atlas.org/study/CHE2008/ · Dataset DOI 10.5281/zenodo.22059963

@misc{atlas_CHE2008,
  author       = {Barton, Oliver},
  title        = {{Oliver's mTOR Atlas}, record CHE2008},
  howpublished = {Data set},
  year         = {2026},
  url          = {https://mtor-atlas.org/study/CHE2008/},
  doi          = {10.5281/zenodo.22059963}
}